VarCov Co’s GoodRx Holdings GDRX Stock Holding History

VarCov Co’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-221,782	Closed	-$435K	–	440
2026 Q1	$435K	Sell	221,782 -2,012	-0.9%	-$4.72K	0.16%	239
2025 Q4	$606K	Buy	+223,794	New	+$735K	0.24%	137

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

VarCov Co's GDRX Position: Q2 2026 in Review

VarCov Co sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 221,782 shares — an estimated $435K sold.

VarCov Co first reported a position in GDRX in Q4 2025 and held it in 2 quarters. The position peaked at $606K in Q4 2025. 159 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

VarCov Co reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
VarCov Co sold 221,782 GoodRx Holdings shares in Q2 2026, an estimated $435K.
VarCov Co first reported a position in GoodRx Holdings in Q4 2025 and held it in 2 quarters.
VarCov Co's GoodRx Holdings position peaked at $606K in Q4 2025.
159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.